Reference List of Studies Included in the Meta-Analysis
Albert, M. S., Moss, M. B., Tanzi, R., & Jones, K. (2001). Preclinical prediction of AD using
neuropsychological tests. Journal of the International Neuropsychological Society, 7, 631-639.
Andreasen, N., Minthon, L., Vanmechelen, E., et al. (1999). Cerebrospinal fluid tau and A42 as
predictors of development of Alzheimer's disease in patients with mild cognitive impairment.
Neuroscience Letters, 273, 5-8.
Arnáiz, E., Jelic, V., Almkvist, O., et al. (2001). Impaired cerebral glucose metabolism and cognitive
functioning predict deterioration in mild cognitive impairment. NeuroReport, 12, 851-855.
Bäckman, L., & Small, B. J. (1998). Influences of cognitive support on episodic remembering: Tracing the
process of loss from normal aging to Alzheimer’s disease. Psychology and Aging, 13, 267-276.
Bäckman, L., Small, B. J., & Fratiglioni, L. (2001). Stability of the preclinical episodic memory deficit in
Alzheimer´s disease. Brain, 124, 96-102.
Bacon, A-W., Bondi, M. W., Salmon, D. P., & Murphy, C. (1998). Very early changes in the olfactory
functioning due to Alzheimer's disease and the role of Apolipoprotein E in ol Daly, E., Zaitchik, D.,
Copeland, M., Schmahmann, J., Gunther, J., & Albert, M. (2000). Predicting conversion to
Alzheimer's disease using standardized clinical information. Archives of Neurology, 57, 675-680.
Bizdan, L., & Bizdan, M. (2002). The predictive value of MMSE, ADAS-Cog, IADL, and PSMS as
instruments for the diagnosis of preclinical phase of dementia of the Alzheimer type. Archives of
Psychiatry and Psychotherapy, 2, 25-34.
Bondi, M. W., Salmon, D. P., Galasko, D., Thomas, R.-G., & Thal L. J. (1999). Neuropsychological
function and apolipoprotein E genotype in the preclinical detection of Alzheimer's disease.
Psychology and Aging, 14, 295-303.
Chen, P., Ratcliff, G., Belle, S. H., Cauley, J. A., DeKosky, S. T., & Ganguli, M. (2000). Cognitive tests
that best discriminate between presymptomatic AD and those who remain nondemented. Neurology,
55, 1847-1853.
Convit, A., Asis, J. D., Leon, J. J. D., Tarshish, C. Y., De-Santi, S., & Rusinek, H. (2000). Atrophy of the
medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline
to Alzheimer's disease. Neurobiology of Aging, 21, 19-26.
Daly, E., Zaitchik, D., Copeland, M., Schmahmann, J., Gunther, J., & Albert, M. (2000). Predicting
conversion to Alzheimer´s disease using standardized clinical information. Archives of Neurology,
57, 675-680.
de Leon, M. J., Golomb, J., George, A. E., et al. (1993). The radiologic prediction of Alzheimer disease:
The atrophic hippocampal formation. American Journal of Neuroradiology, 14, 897-906.
Devenand, D. P., Michaels-Marston, K. S., Liu, X., et al. (2000). Olfactory deficits in patients with mild
cognitive impairment predict Alzheimer's disease at follow-up. American Journal of Psychiatry, 15,
1399-1405.
Fabrigoule, C., Rouch, I., Taberly, A., et al. (1998). Cognitive processes in preclinical phase of dementia.
Brain, 121, 135-141.
Fowler, K. S., Saling, M. M., Conway, E. L., Semple, J. M., & Louis, W. J. (2002). Paired-associate
performance in the early detection of DAT. Journal of the International Neuropsychological
Society, 8, 58-71.
Fox, N. C., Warrington, E. K., Seiffer, A. L., Agnew, S. K., & Rossor, M. N. (1998). Presymptomatic
cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective
study. Brain, 121, 1631-1639.
Grober, E., & Kawas, C. (1997). Learning and retention in preclinial and early Alzheimer's disease.
Psychology and Aging, 12, 183-188.
Hall, C. B., Lipton, R. B., Sliwinski, M., & Stewart, M. F. (2000). A change point model for estimating the
onset of cognitive decline in preclinical Alzhiemer's disease. Statistics in Medicine, 19, 1555-1566.
Howieson, D. B., Dame, A., Camicioli, R., et al. (1997). Cognitive markers preceding Alzheimer’s
dementia in the healthy oldest old. Journal of the American Geriatrics Society, 45, 584-589.
Huang, C., Wahlund, L., Dierks, T., et al. (2000). Discrimination of Alzheimer's disease and mild cognitive
impairment by equivalent EEG sources: A cross-sectional and longitudinal study. Clinical
Neurophysiology, 111, 1961-1967.
Jacobs, D. M., Sano, M., Dooneief, G., et al. (1995). Neuropsychological detection and characterization of
preclinical Alzheimer´s disease. Neurology, 45, 317-324.
Jacobsen, M. W., Delis, D. C., Bondi, M. W., & Salmon, D. P. (2002). Do neuropsychological tests detect
preclinical Alzheimer’s disease: Individual-test versus cognitive-discrepancy score analyses.
Neuropsychology, 16, 132-139.
Jelic, V., Johansson, S. E., Almkvist, O., et al. (2000). Quantitative electroencephalography in mild
cognitive impairment: longitudinal changes and possible prediction of Alzheimer's disease.
Neurobiology of Aging, 21, 533-540.
Kogure, D., Matsuda, H., Ohnishi, T., et al. (2000). Longitudinal evaluation of early Alzheimer's disease
using brain perfusion SPECT. Journal of Nuclear Medicine, 41, 1155-1162.
Lange, K. L., Bondi, M. W., Salmon, D. P., et al. (2002). Decline in verbal memory during preclinical
Alzheimer’s disease: Examination of the effect of APOE genotype. Journal of the International
Neuropsychological Society, 8, 943-955.
Lindeboom, J., Schmand, B., Tulner, L., Walstra, G., & Jonker, C. (2002). Visual association test to detect
early dementia of the Alzheimer type. Journal of Neurology, Neurosurgery, and Psychiatry, 73,
126-133.
Lindsay, J., Laurin, D., Verreault, R., et al. (2002). Risk factors for Alzheimer’s disease: A prospective
analysis from the Canadian Study of Health and Aging. American Journal of Epidemiology, 156,
445-453.
Linn, R. T., Wolf, P. A., Bachman, D. L., et al. (1995). The “preclinical phase” of probable Alzheimer’s
disease. Archives of Neurology, 52, 485-490.
Meyer, J. S., Xu, G., Thornby, J., Chowdhury, M., & Quach M. (2002). Longitudinal analysis of abnormal
domains comprising mild cognitive impairment (MCI) during aging. Journal of the Neurological
Sciences, 201, 19-25.
Nielson, H., Lolk, A., Andersen, K., Andersen, J., & Kragh-Sorensen, P. (1999). Characteristics of elderly
who develop Alzheimer’s disease during the next two years – A neuropsychological study using
CAMCOG. The Odense study. International Journal of Geriatric Psychiatry, 14, 957-963.
Okamura, N., Arai, H., Maruyama, M., et al. (2002). Combined analyses of CSF tau levels and [(123)]
iodoamphetamine SPECT in mild cognitive impairment: Implications for a novel predictor of
Alzheimer’s disease. American Journal of Psychiatry, 159, 474-476.
Olichney, J. M., Morris, S. K., Ochoa, C., et al. (2002). Abnormal verbal event-related potentials in mild
cognitive impairment and incipient Alzheimer’s disease. Journal of Neurology, Neurosurgery, and
Psychiatry, 73, 377-384.
Riemenschneider, M., Lautenschlager, N., Wagenpfeil, S., et al. (2002). Cerebrospinal fluid tau and amyloid 42 proteins identify Alzheimer disease in subjects with mild cognitive impairment.
Archives of Neurology, 59, 1729-1734.
Rubin, E. H., Storandt, M., Miller, J. P., et al. (1998). A prospective study of cognitive function and onset
of dementia in cognitively healthy elders. Archives of Neurology, 55, 395-401.
Schaub, R. T., Anders, D., Golz, G., Gohringer, K., & Hellweg, R. (2002). Serum nerve growth factor
concentration and its role in the preclinical stage of dementia. American Journal of Psychiatry,
159, 1227-1229.
Schmand, B., Walstra, G., Lindeboom, J., Teunisse, S., & Jonker, C. (2000). Early detection of Alzheimer's
disease using the Cambridge Cognitive Examination (CAMCOG). Psychological Medicine, 30,
619-627.
Small, B. J., Fratiglioni, L., Viitanen, M., Winblad, B., & Bäckman, L. (2000). The course of cognitive
impairment in preclinical Alzheimer´s disease: 3- and 6-year follow-up of a population-based
sample. Archives of Neurology, 57, 839-844.
Small, B. J., Herlitz, A., Fratiglioni, L., Almkvist, O., & Bäckman, L. (1997). Cognitive predictors of
incident Alzheimer’s disease: A prospective longitudinal study. Neuropsychology, 11, 413-420.
Small, B. J., Viitanen, M., & Bäckman, L. (1997). Mini-Mental State Examination Scores as predictors of
Alzheimer’s disease: Incidence data from the Kungsholmen Project, Stockholm. Journal of
Gerontology: Medical Sciences, 52, 299-304.
Smith, G. E, Bohac, D. L., Waring, S. C., et al. (1998). Apolipoprotein E genotype influences cognitive
"phenotype" in patients with Alzheimer's disease but not in healthy control subjects. Neurology, 50,
355-362.
Tabert, M. H., Albert, S. M., Borukhova-Milov, L., et al. (2002). Functional deficits in patients with mild
cognitive impairment: Prediction of AD. Neurology, 58, 758-764.
Tierney, M. C., Szalai, J. P., Dunn, E., Geslani, D., & McDowell, I. (2000). Prediction of probable
Alzheimer disease in patients with symptoms suggestive of memory impairment. Archives of
Family Medicine, 9, 527-532.
Tierney, M. C., Szalai, J. P., Snow, W. G., et al. (1996). Prediction of probable Alzheimer’s disease in
memory-impaired patients: A prospective longitudinal study. Neurology, 46, 661-665.
Tröster, A. I., Moe, K. E., Vitiello, M. V., & Prinz, P. N. (1994). Predicting long-term outcome in
individuals at risk for Alzheimer's disease with the Dementia Rating Scale. Journal of
Neuropsychiatry and Clinical Neurosciences, 6, 54-57.
Tuokko, H., Vernon-Wilkinson, J., Weir, J., & Beattie, B. L. (1991). Cued recall and early identification of
dementia. Journal of Clinical and Experimental Neuropsychology, 13, 871-879.
Visser, P. J., Verhey, F. R., Ponds, R. W. H. M., & Jolles, J. (2001). Diagnosis of preclinical Alzheimer’s
disease in a clinical setting. International Psychogeriatrics, 13, 411-423.
Wolf, H., Ecke, G. M., Bettin, S., Dietrich, J., & Gertz, H. J. (2000). Do white matter changes contribute to
the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study.
International Journal of Geriatric Psychiatry, 15, 803-812.